Stock ScreenerStock IdeasHigh Risk, High RewardHigh Risk, High Reward StocksSpeculative companies with the highest upside potential according to WallStreet analysts. Proceed with extreme caution!
Stock ScreenerStock IdeasHigh Risk, High Reward
Consensus: Strong Buy + 1 more
Analysts: >= 2
Upside/Downside: >= 500%
| Ticker | Company | Country | Market Cap | Shares | Institutional % | Insider % | Net Insider (L12M) | Net Insider (L3M) |
|---|---|---|---|---|---|---|---|---|
| GLYC | GLYCOMIMETICS INC | United States | $19.27M | 64,464,412 | 36.65% | 63.35% | Net Buying | Net Buying |
| INTZ | INTRUSION INC | United States | $7.99M | 4,904,195 | 0.24% | 99.76% | Net Buying | Net Buying |
| ASLN | ASLAN PHARMACEUTICALS LTD | Singapore | $8.29M | 466,761,105 | 0.64% | 0.00% | ||
| PPBT | PURPLE BIOTECH LTD | Israel | $10.99M | 198,386,080 | 1.32% | 0.00% | ||
| BPTH | BIO-PATH HOLDINGS INC | United States | $3.54M | 1,656,235 | 0.11% | 99.89% | ||
| IQ | IQIYI INC | China | $5.05B | 6,716,137,085 | 4.72% | 0.00% | ||
| CLNN | CLENE INC | United States | $47.52M | 128,433,721 | 5.68% | 52.66% | Net Buying | Net Selling |
| BIOL | BIOLASE INC | United States | $5.31M | 33,394,979 | 1.42% | 55.47% | ||
| APLM | APOLLOMICS INC | United States | $29.71M | 89,495,790 | 10.33% | 0.00% | ||
| LIFE | ATYR PHARMA INC | United States | $138.02M | 69,010,940 | 60.58% | 22.13% | Net Buying | |
| GOSS | GOSSAMER BIO INC | United States | $157.00M | 226,218,652 | 85.80% | 14.20% | Net Buying | Net Selling |
| LYRA | LYRA THERAPEUTICS INC | United States | $23.35M | 60,964,859 | 74.71% | 14.19% | Net Buying | |
| OCUP | OCUPHIRE PHARMA INC | United States | $43.68M | 25,924,158 | 1.12% | 98.88% | Net Buying | Net Buying |
| RVPH | REVIVA PHARMACEUTICALS HOLDINGS INC | United States | $46.62M | 27,918,560 | 19.44% | 38.25% | ||
| MVST | MICROVAST HOLDINGS INC | United States | $130.37M | 317,196,095 | 20.41% | 31.20% | Net Selling | |
| VIRX | VIRACTA THERAPEUTICS INC | United States | $31.69M | 39,272,434 | 3.50% | 96.50% | Net Buying | Net Selling |
| CKPT | CHECKPOINT THERAPEUTICS INC | United States | $69.28M | 36,850,279 | 14.58% | 8.97% | Net Selling | Net Selling |
| APTO | APTOSE BIOSCIENCES INC | Canada | $19.25M | 16,309,393 | 6.21% | 65.32% | Net Buying | |
| SYBX | SYNLOGIC INC | United States | $19.32M | 11,707,011 | 5.74% | 94.26% | Net Selling | Net Selling |
| DARE | DARE BIOSCIENCE INC | United States | $49.03M | 101,092,900 | 6.75% | 25.30% | ||
| FEMY | FEMASYS INC | United States | $28.22M | 22,220,718 | 6.63% | 8.01% | ||
| IMRX | IMMUNEERING CORP | United States | $43.59M | 29,653,355 | 40.03% | 46.80% | Net Selling | Net Selling |
| CLDI | CALIDI BIOTHERAPEUTICS INC | United States | $11.61M | 50,924,284 | 5.27% | 34.31% | Net Selling | Net Buying |
| LUMO | LUMOS PHARMA INC | United States | $20.62M | 8,116,488 | 16.51% | 83.49% | Net Buying | Net Buying |
| MIST | MILESTONE PHARMACEUTICALS INC | Canada | $92.67M | 53,260,467 | 58.83% | 24.11% | ||
| TARA | PROTARA THERAPEUTICS INC | United States | $63.62M | 20,589,976 | 12.55% | 87.45% | Net Selling | Net Selling |
| GOEV | CANOO INC | United States | $190.62M | 68,567,495 | 6.24% | 93.76% | Net Buying | |
| CVKD | CADRENAL THERAPEUTICS INC | United States | $6.58M | 16,008,469 | 10.40% | 46.72% | Net Buying | |
| GNLX | GENELUX CORP | United States | $98.54M | 26,996,740 | 22.29% | 5.19% | Net Selling | Net Selling |
| CARA | CARA THERAPEUTICS INC | United States | $41.01M | 54,675,954 | 43.18% | 53.39% | Net Selling | Net Selling |
| INAB | IN8BIO INC | United States | $45.45M | 44,123,949 | 19.55% | 51.06% | Net Buying | |
| GEVO | GEVO INC | United States | $166.07M | 236,232,717 | 29.44% | 11.14% | Net Selling | |
| SONN | SONNET BIOTHERAPEUTICS HOLDINGS INC | United States | $5.73M | 3,112,401 | 1.08% | 98.92% | Net Buying | |
| MRNS | MARINUS PHARMACEUTICALS INC | United States | $73.06M | 54,933,774 | 81.92% | 18.08% | Net Buying | Net Buying |
| TPST | TEMPEST THERAPEUTICS INC | United States | $70.65M | 22,217,265 | 3.46% | 96.54% | ||
| EOSE | EOS ENERGY ENTERPRISES INC | United States | $148.60M | 208,127,550 | 39.64% | 13.96% | Net Selling | Net Buying |
| DDC | DDC ENTERPRISE LTD | China | N/A | 20,158,176 | 0.84% | 0.00% | ||
| AMPX | AMPRIUS TECHNOLOGIES INC | United States | $129.43M | 94,472,655 | 5.22% | 75.78% | Net Selling | Net Buying |
| SPRB | SPRUCE BIOSCIENCES INC | United States | $30.87M | 41,154,799 | 43.66% | 44.89% | Net Selling | Net Selling |
| ACET | ADICET BIO INC | United States | $131.48M | 82,173,503 | 82.35% | 17.65% | Net Buying | |
| CMPS | COMPASS PATHWAYS PLC | United Kingdom | $536.11M | 68,380,857 | 40.09% | 50.20% | Net Selling | Net Selling |
| VOR | VOR BIOPHARMA INC | United States | $123.55M | 68,259,602 | 86.36% | 10.15% | Net Selling | Net Selling |
| AQMS | AQUA METALS INC | United States | $49.25M | 113,226,006 | 18.77% | 15.33% | Net Selling | Net Buying |
| MBRX | MOLECULIN BIOTECH INC | United States | $11.74M | 2,311,536 | 4.04% | 95.96% | Net Buying | |
| SGMT | SAGIMET BIOSCIENCES INC | United States | $147.44M | 31,913,887 | 51.04% | 48.96% | Net Buying | Net Buying |
| NTBL | NOTABLE LABS LTD | Israel | $9.20M | 9,018,261 | 2.95% | 97.05% | Net Selling | |
| CMMB | CHEMOMAB THERAPEUTICS LTD | Israel | $11.96M | 284,379,960 | 0.94% | 5.95% | ||
| IKNA | IKENA ONCOLOGY INC | United States | $69.01M | 48,258,111 | 61.82% | 18.22% | ||
| PGEN | PRECIGEN INC | United States | $348.34M | 252,419,690 | 24.41% | 72.43% | Net Buying | Net Selling |
| FBIO | FORTRESS BIOTECH INC | United States | $38.44M | 19,916,124 | 14.56% | 60.54% | Net Buying | Net Buying |
| CDTX | CIDARA THERAPEUTICS INC | United States | $51.14M | 4,561,708 | 60.41% | 39.59% | Net Selling | Net Selling |
| OTLK | OUTLOOK THERAPEUTICS INC | United States | $182.10M | 23,405,637 | 3.76% | 96.24% | Net Buying | Net Buying |
| AGEN | AGENUS INC | United States | $228.05M | 20,999,261 | 60.95% | 39.05% | Net Buying | Net Buying |
| SBEV | SPLASH BEVERAGE GROUP INC | United States | $13.49M | 47,656,088 | 6.10% | 2.91% | Net Buying | |
| ATAI | ATAI LIFE SCIENCES NV | United States | $286.26M | 167,406,070 | 7.37% | 37.60% | Net Selling | Net Selling |
| HOOK | HOOKIPA PHARMA INC | United States | $80.64M | 98,950,107 | 36.20% | 26.83% | Net Buying | |
| RIGL | RIGEL PHARMACEUTICALS INC | United States | $166.64M | 175,406,146 | 63.28% | 15.75% | Net Selling | |
| CRBU | CARIBOU BIOSCIENCES INC | United States | $306.18M | 90,317,771 | 73.80% | 8.74% | Net Buying | |
| PRST | PRESTO AUTOMATION INC | United States | $17.37M | 80,791,967 | 8.37% | 68.69% | Net Buying | |
| CLRB | CELLECTAR BIOSCIENCES INC | United States | $118.30M | 35,848,924 | 25.47% | 11.43% | ||
| LCTX | LINEAGE CELL THERAPEUTICS INC | United States | $203.90M | 188,798,145 | 39.25% | 60.75% | Net Buying |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.